AI’s role in insurance is already spawning lawsuits and battles over its regulation. That's not slowing down its use.

In five states, estimates reviewed by KFF Health News show that changes will cost at least $45.6 million combined.

The company's Biomea that is the lead program, icovamenib, is the first in the category of menin inhibitors directed to the treatment of both type 1 and type 2 diabetes that holds the potential to ...

Social media sleuths found search results on the Uber Eats app returned restaurant recommendations based on anti-Black, ...